Summit Hotel Properties, Inc. (INN-PF)
| Previous Close | 18.45 |
| Open | 18.25 |
| Bid | 18.75 x 800 |
| Ask | 18.92 x 800 |
| Day's Range | 18.25 - 18.85 |
| 52 Week Range | 17.11 - 27.02 |
| Volume | |
| Avg. Volume | 5,640 |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.47 (8.39%) |
| Ex-Dividend Date | Feb 11, 2022 |
| 1y Target Est | N/A |
- Newsfile
Innocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: "It Was as If a New Dog Came into Our Lives"
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful preclinical trials in dogs with osteoarthritis. A case entailing the clinical condition of Goody, an 8-year-old male mixed-breed dog, who was rescued in a terrible condition after he was found tied up with a very short leash, cachectic and wounded, was published. Goody suffers from ...
- Newsfile
Innocan Pharma Announces Filing of PCT Patent Application for Vaginal Atrophy Treatment
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed a new PCT patent application entitled "Compositions for Treatment of Vaginal Atrophy" on June 12, 2022, claiming priority from a US provisional patent. Vaginal atrophy is a condition associated with loss of moisture, thinning, and inflammation of the vaginal walls, which can ...
- Newsfile
Innocan Reports Successful Preliminary Trial Results Regarding Epilepsy in Dogs
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 10, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce the successful preliminary results of a small-scale efficacy trial in dogs with refractory (drug-resistant) epilepsy. In this initial phase, the dogs were treated with Innocan Pharma's LPT (CBD Loaded Liposome Platform) injection. The results demonstrate that these dogs had a decrease in the frequency of ...
